Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Quest for Growth NV Earnings Release 2014

Jan 22, 2015

3991_iss_2015-01-22_13d83003-27b6-4858-a50e-9f4ed7da68f5.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Press release Leuven / 22 January 2015 / 5.40 PM

Regulated information. This press release contains information subject to the European transparency requirements imposed on listed companies..

Quest for growth

Schedule for publication

on 22 January 2015

5.40 PM press release available at www.questforgrowth.com

on 23 January 2015 11.00 AM press & analyst meeting, Capricorn Venture Partners NV, Lei 19, 3000 Leuven

Privak, fixed capital investment company established under Belgian Law

Annual results Quest for Growth

QUEST FOR GROWTH MADE A PROF IT OF € 8.7 MILL ION IN 2014 THE BOARD OF DIRE CTORS PRO POSES A NET DIVIDEN D OF € 0.70 PER ORDINARY SHARE

Key facts:

  • • Return on equity per share: + 7.93 % since 31 December 2013
  • • Net Asset Value per share at December 31st 2014: € 10.28 (December 31st 2013: € 10.87)
  • • Net profit for the fiscal year: + € 8,712,147 (+ € 0.76 per share) against a profit of + € 18,474,284 (+ € 1.60 per share) for the previous fiscal year
  • • Share price at December 31st 2014: € 7.611 (December 31st 2013: € 8.21)
  • • Discount of the share price versus Net Asset Value: 25.98% at December 31st 2014 (24.4 % at December 31st 2013)
  • • The board proposes to the AGM a gross dividend of € 0.72 per ordinary share (net dividend of € 0,70 per ordinary share)

Results

In 2014, Quest for Growth achieved a return on equity of 7.9% (based on 2014's profit against its net asset value after the dividend distribution at the end of the previous financial year). This performance can be qualified as good, even if it is lower than that in the two previous financial years, which each booked performance of a little over 17%. The net asset value per share amounted to 10.28 euros on 31 December 2014. Net profit in 2014 was approximately 8.7 million euros (0.76 euros per share), compared to profit of 18.5 million euros (1.60 euros per share) in 2013.

The share price closed the year at 7.61 euros, against 8.21 euros at the end of the previous year. Taking account of the dividend, overall performance of the Quest for Growth share over the past year was nearly 7%. The share price's discount against the net asset value was 26% on 31 December 2014, as opposed to 24% on 31 December 2013.

Allocation of the result

The board of directors proposes to the shareholders in general meeting that the profit balance to be allocated, in the sum of 8,700,784 euros, should be distributed. This results in a gross dividend for the ordinary shares of 0.72 euros per share (net: 0.70 per share). A balance of 11,363 euros is carried forward to the next financial year. Once approved by the AGM, the dividend will be paid on 26 March 2015.

Market environment

Following an excellent stock market year in 2013, 2014 proved somewhat more difficult, especially for European shares. The hoped-for improvement in Europe's economy did not truly emerge and, even in Germany, the euro area's stalwart in past years, there were signs of weakness. The European DJ Stoxx 600 stock market index was nonetheless able to notch up a rise of 4.4% over the full year. In Europe, small caps performed less well than large caps. The DJ Stoxx Small 200 index rose by only 2.7%.

Investments in listed companies

With estimated performance (before charges) of around 7% in 2014, a decent, if not exceptional, result was achieved in the listed share portfolio. Two of the shares invested in made a particular mark: Melexis (+67% performance) and Nemetschek (+70%). EVS (-32%), Centrotec (-22%) and Econocom (-35% until being sold) were the shares that made the most negative contribution to performance.

In 2014, four shares were sold off completely: U-Blox, Ablynx, Barco and Econocom. On the last of these shares, which disappeared entirely from the portfolio in the fourth quarter, a handsome profit was booked compared to the purchase price in 2010. The shares introduced in 2014 were FMC Corp, USU Software, TKH Group and Nibe.

Investments in unquoted companies

In line with the expectations voiced in the previous year that exit opportunities would increase, the portfolio of unlisted shares achieved a strong result in 2014. This is due to the investment in Clear2Pay, which was acquired by FIS Global. For Quest for Growth, that deal had a positive impact on its intrinsic value, of 4.7 million euros, or 0.41 euros per share. At the end of 2014, Quest for Growth invested 1 million euros in Avantium, an unlisted Dutch company operating in the area of bio-based chemicals and bioplastics. Avantium was already an indirect investment of Quest for Growth via the Capricorn Cleantech Fund. This additional direct holding is to be viewed as a co-investment with Capricorn Cleantech Fund.

Venture capital funds

The result from investments in venture capital funds was also positive in 2014. An important positive contribution came from the funds of LSP (Life Science Partners). The price of Prosensa, one of their holdings, made a strong recovery in 2014 and, in November, this was followed by an offer for the company, with a premium of 55% over the latest price. The increased valuations in Capricorn Healthtech Fund also had a positive impact, due in part to market flotations by Mainstay Medical and Nexstim.

Capricorn ICT Arkiv raised its subscribed capital from 15 million euros to 33.2 million euros in 2014, further to which Quest for Growth increased its share in the fund's subscribed capital from 9 million to 11.5 million euros. The most recent investment by Capricorn ICT Arkiv is FEops, which is a spin-off from the University of Ghent focusing on the pre-operative planning of cardiovascular implants based on a patient-specific 3D model.

Prospects

The economic indicators from the past few months show that Europe is continuing to flounder whereas the US economy remains strong. The average forecast price/earnings ratio of the shares in the portfolio has further increased to more than 15.5, compared to a little over 15 a year ago. The interest rate in Europe has fallen to a hitherto unseen lowpoint, making shares relatively more attractive. If this environment of low, but positive, growth and low interest rates continues, further rises in the stock market are possible, albeit there are no expectations of very high returns.

After the sale of Clear2Pay, additional exits from the remaining direct investments in unlisted companies continue to be possible if the market environment for acquisitions and flotations remains favourable. The timing of such exits is very difficult to predict. In 2015, Capricorn ICT Arkiv will endeavour to further develop a portfolio of promising, innovative companies. For Capricorn Health-tech Fund, we are expecting two further new investments in 2015. Further co-investments with the Capricorn funds also continue to be a possibility.

The General Assembly will take place on 19 March 2015 in Leuven.

Total shareholders return ( 31/12/2011 – 31/12/2014)

Discount of the share price versus the net asset value until 31 December 2014

Results from 31/12/2005 until 31/12/2014

1. Balance sheet 2014
31 December
2013
31 December
2012
31 December
2011
31 December
2010
31 December
ASSETS
Fixed assets 110,414,970 120,264,108 104,265,373 86,989,456 99,778,377
Formation expenses 0 0 0 0 0
Financial assets 110,414,970 120,264,108 104,265,373 86,898,456 99,778,377
Shares 98,488,620 106,950,253 100,625,585 79,492,057 93,078,608
Amounts receivable 11,926,350 13,313,854 3,639,788 7,497,399 6,699,769
Current assets 8,229,318 5,083,517 2,632,925 4,203,529 6,298,058
Amounts receivable in more than one year 1,399,479 666,305 0 0 885,932
Trade receivables 1,399,479 666,305 0 0 0
Other receivables 0 0 0 0 885,932
Amounts receivable within one year 150,425 70,187 689,618 1,165,102 98,934
Trade receivables 0 0 0 0 0
Other receivables 150,425 70,187 689,618 1,165,102 98,934
Short term investments 0 0 0 0 1,376,910
Own shares 0 0 0 0 1,376,910
Term deposits 0 0 0 0 0
Cash at bank and in hand 6,670,317 4,280,362 1,867,036 3,038,427 3,724,105
Deferred charges and accrued income 15,192 66,662 76,271 31,501 212,177
TOTAL ASSETS 118,650,383 125,347,624 106,898,298 91,224,485 106,076,435
LIABILITIES
Capital and reserves 109,848,623 109,837,261 106,803,118 91,101,307 106,009,655
Issued capital 109,748,742 109,748,742 109,748,742 109,748,742 109,748,742
Reserves 0 0 656,423 656,423 2,251,148
Reserves not available for distribution 0 0 0 0 1,376,910
Reserves available for distribution 0 0 656,423 656,423 874,239
Profit carried forward 99,881 88,518 0 0 0
Loss carried forward 0 0 (3,602,048) (19,303,859) (5,990,236)
Amount payable 8,801,760 15,510,364 95,180 123,179 66,779
Amounts payable within one year 8,745,601 15,478,430 43,405 105,882 66,291
Financial debts 0 0 0 0 0
Trade debts 0 0 4,971 55,358 7,865
Taxes 162 346 447 432 70
Dividends to be paid for the fiscal year 8,700,784 15,440,141 0 0 0
Other amounts payable 44,655 37,944 37,987 50,092 58,356
Accrued charges and deferred income 56,159 31,933 51,775 17,297 488
2. Income statement Fiscal year
2014
Fiscal year
2013
Fiscal year
2012
Fiscal year
2011
Fiscal year
2010
Operating income and charges
Gross operating income 9,605,175 18,769,640 16,549,688 (13,327,578) 21,373,611
Realised gains/losses on shares 11,254,192 15,008,104 822,772 1,975,022 14,229,612
Unrealised gains/losses on shares (876,639) 3,468,769 15,799,482 (15,131,517) 7,108,393
Result from option transactions 14,000 80,840 46,758 60,200 254,920
Realised results from Forward currency rate
agreements
(739,794) 236,355 (76,147) (37,391) (457,777)
Unrealised results from Forward currency
rate agreements
(46,584) (24,428) (43,177) (193,893) 238,462
Other operating charges (1,930,404) (1,994,093) (1,988,074) (1,904,226) (1,973,725)
Management fee (1,432,944) (1,464,878) (1,473,230) (1,500,000) (1,610,959)
Custodian fee (53,264) (52,926) (44,011) (45,323) (43,940)
Statutory Auditors fee (12,464) (12,270) (9,767) (11,680) (9,183)
Printing and publication costs (62,662) (75,552) (101,118) (76,974) (64,155)
Annual tax on Collective Investment sche
mes
(101,599) (103,065) (72,881) (84,808) (67,763)
Directors fees (188,750) (207,550) (204,770) (93,730) (72,398)
Advisory fees (17,252) (7,049) (19,645) (17,852) (34,683)
Others (61,468) (70,803) (62,652) (73,859) (70,602)
Operating Profit/Loss 7,674,771 16,775,548 14,561,614 (15,231,804) 19,399,928
Financial income 1,234,652 1,648,886 1,646,024 1,770,100 1,394,583
Financial charges (197,246) 49,749 (505,741) 148,442 (226,358)
Amounts written off own shares* (0) (0) 0 217,816 171,141
Amounts written off other current assets (74,695) 254,103 (383,871) (0) (0)
Others (122,552) (204,354) (121,868) (69,373) (397,350)
Profit/Loss on ordinary activities, before
taxes
8,712,176 18,474,183 15,701,897 (13,313,262) 20,568,153
Income taxes (29) (101) (86) (362) (70)
Profit/Loss for the period 8,712,147 18,474,284 15,701,811 (13,313,623) 20,568,083
Profit / Loss for the period, after taxes, per
share
0.76 1.60 1.36 (1.15) 1.74

*Reversal of impairment on treasury shares before annulment on June 29th 2011

3. Profit distribution Fiscal year
2014
Fiscal year
2013
Fiscal year
2012
Fiscal year
2011
Fiscal year
2010
Profit to be appropriated 8,800,665 14,872,236
Loss to be appropriated (3,602,048) (19,303,859) (5,990,236)
Profit to be appropriated for the period 8,712,147 18,474,284 15,701,811 20,568,083
Loss to be appropriated for the period (13,313,623)
Profit/loss brought forward 88,518 (3,602,048) (19,303,859) (5,990,236) (26,558,319)
Transfers from capital and reserves 0 656,423
From reserves 0 656,423
Transfers to capital and reserves
To other reserves
Profit/loss to be carried forward 99,881 88,518 (3,602,048) (19,303,859) (5,990,236)
Profit to be carried forward 99,881 88,518
Loss to be carried forward (3,602,048) (19,303,859) (5,990,236)
Distribution of profit 8,700,784 15,440,141
Dividends 8,700,784 15,440,141

4. Report of the statutory auditor

The statutory auditor, Klynveld Peat Marwick Goerdeler Bedrijfsrevisoren – Réviseurs d'Entreprises, represented by Mr. Erik Clinck, has issued an unqualified audit opinion on the financial statements of the fiscal year 2013 and has confirmed that the accounting data included in this annual announcement does not include any apparent inconsistencies with the financial statements.

The annual financial report including the audited annual accounts, the annual report, the statement on the true and fair view of the annual accounts and the fair overview in the annual report by the responsible persons and the report of the Statutory Auditor shall be available as from February 16th 2015, on request at the registered office: Lei 19 box 3, 3000 Leuven, Belgium.

QUEST FOR GROWTH NV Privak, fixed capital investment company established under Belgian Law Lei 19, box 3 B-3000 Leuven - Phone: +32 (0)16 28 41 28 - Fax: +32 (0)16 28 41 29